Symbyax

   
Google
 
Web NewDrugInformation.com

Symbyax


Drug - Symbyax
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fluoxetine Hydrochloride; Olanzapine
Multiple ingredients are in alphabetical order.

Strength - EQ 25MG BASE;EQ 6MG BASE
The potency of the active ingredient(s), Fluoxetine Hydrochloride; Olanzapine. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Symbyax. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021520
The FDA assigned number to Symbyax. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Symbyax. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 24, 2003
The date Symbyax was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Symbyax. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Symbyax is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Symbyax.

Symbyax